BioWorld

July 19, 2006

Senate OKs ESC Funding Bill, But Quick Veto Likely

WASHINGTON - Although the Senate voted on Tuesday to pass a bill to expand federal funding for embryonic stem cell research, President Bush is likely to soon stop the measure in its tracks. (BioWorld Today) Read More

Crucell Shares Fall After Aerugen Program Ended

FDA Wants More On CAIV-T, But MedImmune On Course

Cadence Files For $86M IPO; Osiris Provides Price Range

Other News To Note

Clinic Roundup

Today's news in brief

BioWorld

BioWorld briefs for Dec. 17, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 17, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

Drug duo to Repare lack in gyno cancers? Phase I shows promise

BioWorld

Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

Mechanism underlying so-called idiopathic autism inception unveiled

BioWorld Science

Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...